Study finds diminished Covid vaccine response in immunocompromised patients

Posed by model. Credit: Getty/Ridofranz

By Olivia Bowthorpe

Patients on immunotherapy such as rituximab have a diminished response to SARS-CoV-2 vaccinations, research indicates.

Ravi Gupta, professor of clinical microbiology at the University of Cambridge, told Doctors.net.uk: "In the Omicron era, individuals who are immune suppressed, and particularly those using B cell depletion therapy will likely need boosting with variant specific vaccines at more regular intervals than the general population.